Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients
Status:
Terminated
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare two different therapies for actinic keratoses in
organ transplant recipients with regard to efficacy and tolerability. The investiagtors are
planning to examine treatment with Imiquimod 5% cream versus treatment with
Methyl-aminolaevulinate 16% cream and subsequent irradiation with red light, so-called
photodynamic therapy, in this patients' group. A secondary objective of our study is to
investigate the reduction in the field cancerisation after both treatments using fluorescence
diagnostic method and digital imaging.